BRIEF published on 08/01/2024 at 07:05, 1 month 19 days ago AT&S enregistre une légère tendance à la hausse au premier trimestre AT&S Perspectives Du Marché BAIIA Résultats Du Premier Trimestre Revenu
BRIEF published on 08/01/2024 at 07:05, 1 month 19 days ago AT&S Records Slight Upward Trend in the First Quarter EBITDA Revenue AT&S Market Outlook Q1 Results
PRESS RELEASE published on 08/01/2024 at 07:00, 1 month 19 days ago AT&S records slight upward trend in the first quarter AT&S records 1% revenue increase in Q1 2024/25. CEO outlines market challenges and efficiency measures. Company prepares for production at new plants in Malaysia and Austria Revenue Increase Market Challenges AT&S Efficiency Measures New Plants
BRIEF published on 07/11/2024 at 09:33, 2 months 9 days ago Authorisation Resolution of the AGM for Convertible Bonds Convertible Bonds AT&S Financial Authorization AGM Resolution
BRIEF published on 07/11/2024 at 09:33, 2 months 9 days ago Résolution d'autorisation de l'Assemblée générale pour les obligations convertibles AT&S Liens Convertibles Autorisation Financière Résolution De L'AGA
PRESS RELEASE published on 07/11/2024 at 09:28, 2 months 9 days ago Authorisation resolution of the AGM for convertible bonds AT&S AGM authorizes issuance of convertible bonds up to EUR 400 million with conversion rights for new shares. Details in German-language resolution Convertible Bonds AGM AT&S Issuer Authorization General Meeting Resolution
BRIEF published on 07/04/2024 at 15:54, 2 months 16 days ago Résultats de l'assemblée générale annuelle d'AT&S Dividende AT&S Assemblée Générale Annuelle Résultats Du Vote Deloitte
BRIEF published on 07/04/2024 at 15:54, 2 months 16 days ago Results of the AT&S Annual General Meeting Annual General Meeting Voting Results Dividend AT&S Deloitte
PRESS RELEASE published on 07/04/2024 at 15:49, 2 months 16 days ago Results of the AT&S Annual General Meeting AT&S Annual General Meeting decides not to pay dividend for 2023/24, appoints Deloitte as auditor for 2024/25. All agenda items approved. Visit www.ats.net for more details Annual General Meeting Auditor Dividend AT&S Deloitte
BRIEF published on 05/14/2024 at 07:06, 4 months 6 days ago AT&S Projects Revenue Growth and Market Recovery in FY 2024/25 AI Technology Market Recovery Financial Forecast AT&S Annual Results
Published on 09/20/2024 at 23:40, 2 hours 9 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 2 hours 19 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 2 hours 49 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 3 hours 19 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 3 hours 34 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 2 hours 51 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 4 hours 49 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 5 hours 35 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 5 hours 59 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 6 hours 2 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 8 hours 9 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 8 hours 9 minutes ago Mise à disposition du Rapport Financier Semestriel 2024